z-logo
open-access-imgOpen Access
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
Author(s) -
Jordana K. Schmier
Publication year - 2010
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s10486
Subject(s) - bimatoprost , travoprost , latanoprost , medicine , benzalkonium chloride , prostaglandin analogue , prostaglandin , glaucoma , population , eyelash , expert opinion , ophthalmology , intensive care medicine , environmental health , pathology , genetics , biology
To estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom